| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.25B | 63.90B | 61.01B | 59.53B | 56.50B | 53.17B |
| Gross Profit | 19.91B | 19.88B | 19.73B | 19.04B | 17.98B | 16.73B |
| EBITDA | 7.19B | 7.18B | 6.90B | 6.64B | 6.17B | 5.80B |
| Net Income | 2.76B | 2.67B | 2.17B | 2.10B | 1.92B | 1.88B |
Balance Sheet | ||||||
| Total Assets | 41.61B | 41.58B | 40.88B | 38.98B | 38.15B | 36.61B |
| Cash, Cash Equivalents and Short-Term Investments | 960.00M | 1.04B | 2.11B | 1.95B | 1.93B | 2.44B |
| Total Debt | 16.73B | 25.14B | 19.18B | 18.17B | 17.61B | 16.55B |
| Total Liabilities | 30.56B | 30.39B | 29.61B | 27.36B | 26.69B | 24.88B |
| Stockholders Equity | 10.91B | 11.03B | 11.09B | 11.46B | 11.30B | 11.57B |
Cash Flow | ||||||
| Free Cash Flow | 4.43B | 4.10B | 3.60B | 3.58B | 3.18B | 3.65B |
| Operating Cash Flow | 6.26B | 5.81B | 5.80B | 5.65B | 4.75B | 4.83B |
| Investing Cash Flow | -2.02B | -1.89B | -2.02B | -1.84B | -2.37B | -1.27B |
| Financing Cash Flow | -4.23B | -3.99B | -3.82B | -3.93B | -2.75B | -3.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$16.55B | 24.90 | 9.98% | 1.89% | -3.40% | ― | |
71 Outperform | C$50.87B | 38.24 | 94.71% | 0.20% | 16.11% | 11.08% | |
70 Outperform | C$19.24B | 19.25 | 14.38% | 1.50% | 3.52% | 5.04% | |
66 Neutral | C$75.28B | 27.42 | 24.88% | 1.52% | 4.36% | 28.73% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | C$11.50B | 73.90 | 2.98% | 1.78% | 2.15% | -70.90% | |
57 Neutral | C$38.84B | 33.56 | 21.74% | 1.23% | 4.36% | -0.82% |